Results 41 to 50 of about 994,937 (217)

Real‐World Disparities in Remote Follow‐Up of Cardiac Implantable Electronic Devices and Impact of the COVID‐19 Pandemic: A Single‐Center Experience

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023
Background Remote monitoring (RM) of cardiac implantable electronic devices has been shown to improve cardiovascular morbidity and mortality. To date, no studies have investigated disparities in use and delivery of RM.
H. Immo Lehmann   +9 more
doaj   +1 more source

Sonogenetics is a novel antiarrhythmic treatment [PDF]

open access: yesarXiv, 2021
Arrhythmia of the heart is a dangerous and potentially fatal condition. The current widely used treatment is the implantable cardioverter defibrillator (ICD), but it is invasive and affects the patient's quality of life. The sonogenetic treatment technique proposed here focuses transthoracic ultrasound on the heart, noninvasively stimulates endogenous ...
arxiv  

Intra-operative defibrillation testing and clinical shock efficacy in patients with implantable cardioverter-defibrillators: the NORDIC ICD randomized clinical trial

open access: yesEuropean Heart Journal, 2015
Aims This trial was designed to test the hypothesis that shock efficacy during follow-up is not impaired in patients implanted without defibrillation (DF) testing during first implantable cardioverter-defibrillator (ICD) implantation. Methods and results
D. Bänsch   +11 more
semanticscholar   +1 more source

Pseudo inappropriate shock: A technical dilemma

open access: yesAnnals of Cardiac Anaesthesia, 2019
With liberal availability of high end cardiac implantable devices in recent era, we frequently encounter patients who are recipients of implantable cardioverter defibrillators (ICDs) in our routine clinical practice.
Pujan J Shah, Aditya Kapoor
doaj   +1 more source

Inappropriate ICD Shock as a Result of TASER Discharge

open access: yesJACC: Case Reports, 2020
Conducted energy weapon (commonly known as TASER) discharge in patients with implantable cardioverter-defibrillators is known to cause electromagnetic interference and inappropriate ventricular fibrillation sensing without delivery of implantable ...
Chirag R. Barbhaiya, MD   +9 more
doaj  

Continuous ST‐Monitoring Function of Implantable Cardioverter Defibrillator Detects Silent Ischemia in Patients With Coronary Artery Disease

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2018
Background Newer implantable cardioverter defibrillators can monitor intracardiac ECGs , but their ability to detect ischemia is unclear. This study investigated the usefulness of implantable cardioverter defibrillators with an ST‐monitoring function in ...
Tetsuya Watanabe   +13 more
doaj   +1 more source

T-Wave Oversensing with Contemporary Implantable Cardioverter–Defibrillators

open access: yesJournal of Cardiovascular Development and Disease, 2023
Background: Implantable cardioverter–defibrillators (ICDs) need to reliably detect ventricular tachycardia (VT) and ventricular fibrillation (VF) while avoiding T-wave oversensing (TWOS), which is associated with a risk of inappropriate therapies.
Marc Strik   +7 more
doaj   +1 more source

Deep learning methods for screening patients' S-ICD implantation eligibility [PDF]

open access: yesarXiv, 2021
Subcutaneous Implantable Cardioverter-Defibrillators (S-ICDs) are used for prevention of sudden cardiac death triggered by ventricular arrhythmias. T Wave Over Sensing (TWOS) is an inherent risk with S-ICDs which can lead to inappropriate shocks. A major predictor of TWOS is a high T:R ratio (the ratio between the amplitudes of the T and R waves ...
arxiv  

Evaluation and Monitoring of Patients With Cardiovascular Implantable Electronic Devices Undergoing Noncardiac Surgery

open access: yesHealth Services Insights, 2017
In this article, the reader will get some insights into managing patient with implantable cardiac devices while undergoing noncardiac surgery.
Eduard Sklyar, Jonathan N Bella
doaj   +1 more source

Gender differences in appropriate shocks and mortality among patients with primary prophylactic implantable cardioverter-defibrillators: Systematic review and meta-analysis [PDF]

open access: yesPLoS ONE 11(9):e0162756, 2016, 2016
BACKGROUND: Some but not all prior studies have shown that women receiving a primary prophylactic implantable cardioverter defibrillator (ICD) have a lower risk of death and appropriate shocks than men. PURPOSE: To evaluate the effect of gender on the risk of appropriate shock, all-cause mortality and inappropriate shock in contemporary studies of ...
arxiv   +1 more source

Home - About - Disclaimer - Privacy